C. Marino

Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.

C. Zoccali, M. Postorino, G. Tripepi, 2009, Journal of the American College of Cardiology.

Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden.

C. Zoccali, M. Postorino, G. Tripepi, 2008, Kidney international. Supplement.

Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients.

C. Zoccali, F. Mallamaci, P. Fatuzzo, 1999, Journal of nephrology.

Blood Pressure in relation to 24-Hour Urinary Sodium and Potassium Excretion in a Uruguayan Population Sample

J. Staessen, J. Boggia, O. Noboa, 2018, International journal of hypertension.

Salivary and lacrimal secretion is reduced in patients with ESRD.

C. Zoccali, M. Postorino, C. Catalano, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prognostic value of the New York Heart Association classification in end-stage renal disease.

C. Zoccali, M. Postorino, G. Tripepi, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients.

C. Zoccali, M. Postorino, G. Tripepi, 2011, Kidney international.